Phase 2a trial to investigate 5-MeO-DMT candidate for alcohol use disorder

Beckley Psytech and Clerkenwell Health are collaborating on a Phase 2a trial investigating Beckley’s synthetic 5-MeO-DMT candidate combined with psychological support as a treatment for alcohol use...